Pharmaceuticals

Sort by Latest
Public Procurement for Biological Medicines in Belgium: The Royal Decree of 13 September 2023 opens the door for compulsory tendering when biosimilars enter the market. Can virtue afford to flirt with legality?
In general The Royal Decree of September 13, 2023 (‘RD’), implementing Article 71bis, § 1, of the Belgian Act on Compulsory Health Care Insurance and Benefits (‘Wet betreffende de verplichte verzekering voor geneeskundige verzorging en uitkeringen’), which establishes specific regulations for public procurement concerning biological medicines, was published in the Belgian Official Gazette on September 22, 2023. The impact of this Royal Decree on the sector could be significant,...
September 27, 2023
7 min read
Reforming the European pharmaceutical legislation:...
This article is part of a series that covers the proposed...
August 7, 2023
5 min read
What does the European Commission’s proposed reform...
This article is part of a series that covers the proposed...
July 26, 2023
4 min read
Reform of the EU pharmaceutical legislation: proposals...
This article is part of a series that covers the proposed...
July 10, 2023
4 min read
Increased interest in the use of psychedelics as mainstream therapies
 ul { list-style-type: disc; padding-left: 40px; } ol { list-style-type: d...
July 4, 2023
6 min read
Proposed reform of the EU pharmaceutical legislation: New regime for orphan medicinal products under the proposed regulation
This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation....
June 27, 2023
4 min read
Strengthened Environmental Risk Assessment requirements under the proposed new directive on medicinal products for human use
This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation....
June 23, 2023
3 min read
What the replication crisis means for AI and drug discovery
Back in May 2016, the scientific publication Nature surveyed over 1,500 researchers to find out how...
May 4, 2023
2 min read
Revamping the European pharmaceutical industry: A closer look at the EU’s proposed legislative framework
On 26 April 2023, the European Commission published the long-anticipated proposal for the revision of...
April 28, 2023
3 min read